Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 4, 2008, Pages 355-365

  Lahner, E ^a   Corleto, V D ^b   D'Ambra, G ^a   Di Giulio, E ^a   Delle Fave, G ^a   Annibale, B ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1;

ADULT; AGED; ALLELE; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; FOLLOW UP; GENDER; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IL 1B GENE; IL 1RN GENE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METAPLASIA; METHODOLOGY; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DNA; FEMALE; FOLLOW-UP STUDIES; GASTRITIS, ATROPHIC; GASTROSCOPY; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS;

EID: 38149049074     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03581.x     Document Type: Article

References (42)

1. Peterson WL, Graham DY. Helicobacter pylori. In:Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management, 7th edn. Philadelphia, PA:Saunders, 2002:732 46.
2. Haber MM. Histologic precursors of gastrointestinal tract malignancy. Gastroenterol Clin N Am 2002 31:395 419.
3. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992 52:6735 40.
4. Tatsuta M, Iishi H, Nakaizumi A, et al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer 1993 53:70 4.
5. Sjöblom S-M, Sipponen P, Miettinen M, et al. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy 1988 20:52 6.
6. Kokkola A, Sjöblom S-M, Haapiainen R, et al. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. Scand J Gastroenterol 1998 33:88 92.
7. Whiting JL, Sigurdsson A, Rowlands DC, et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002 50:378 81.
8. Koh TJ, Wang TC. Tumors of the stomach. In:Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management, 7th edn. Philadelphia, PA:Saunders, 2002:829 55.
9. Lahner E, Bordi C, Cattaruzza MS, et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther 2005 22:471 81.
10. El Omar EM. The importance of interleukin-1β in Helicobacter pylori associated disease. Gut 2001 48:743 7.
11. Rad R, Dossumbekova A, Neu B, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004 53:1082 9.
12. Chen A, Li C-N, Hsu K-HL, et al. Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Aliment Pharmacol Ther 2004 20:203 11.
13. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002 100:249 60.
14. Eklund C, Jahan F, Pessi T, et al. Interleukin 1B gene polymorphisms is associated with baseline C-reactive protein levels in healthy individuals. Eur Cytokine Netw 2003 14:168 71.
15. Arend WP, Malyak M, Guthridge CJ, et al. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998 16:27 55.
16. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphism associated with increased risk of gastric cancer. Nature 2000 404:398 402.
17. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001 121:823 9.
18. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003 124:1193 201.
19. Machado JC, Figueiredo CV, Canedo P, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003 125:125.
20. Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002 94:1680 7.
21. Furuta T, El Omar EM, Xiao F, Shirai N, Takashima M, Sugimurra H. Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce frisk of duodenal ulcer recurrence in Japan. Gastroenterology 2002 123:92 105.
22. Camargo MC, Mera R, Correa P, et al. Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006 15:1674 87.
23. Annibale B, Marignani M, Azzoni C, et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 1997 2:57 64.
24. Lahner E, Caruana P, D'Ambra G, et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest Endosc 2001 53:443 8.
25. Annibale B, Di Giulio E, Caruana P, et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharmacol Ther 2002 16:1723 31.
26. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993 91:403 4.
27. Wilkening S, Hemminki K, Rudnai P, et al. Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA. Br J Dermatol 2006 155:1139 44.
28. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the Updated Sydney System-International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996 20:1161 81.
29. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: The Padova International Classification. Am J Surg Pathol 2000 24:167 76.
30. Hamilton SR, Aaltonen LA. Pathology & genetics of tumours of the digestive system. In:Hamilton SR, Aaltonen LA, eds. WHO Classification of Tumours, Volume 2. Lyon:IARC Press, 2002:46 8.
31. Annibale B, Azzoni C, Corleto VD, et al. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol 2001 13:1449 56.
32. Hall SK, Perregaux DG, Gabel CA, et al. Correlation of polymorphic variation in the promoter region of the interleukin-1beta gene with secretion of interleukin-1beta protein. Arthritis Rheum 2004 50:1976 83.
33. Schrijver HM, van As J, Crusius JB, et al. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis. Mediators Inflamm 2003 12:89 94.
34. Plummer M, Franceschi S, Munoz N. Epidemiology of gastric cancer. IARC Sci Publ 2004 157:311 26.
35. Ruzzo A, Graziano F, Pizzagalli F, et al. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse type. Ann Oncol 2005 16:887 92.
36. Palli D, Saieva C, Luzzi I, et al. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am J Gastroenterol 2005 100:1941 8.
37. Zambon CF, Basso D, Navaglia F, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2004 126:382 4.
38. Zabaleta J, Camargo MC, Piazuelo MB, et al. Association of interleukin-1β gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians. Am J Gastroenterol 2006 101:163 71.
39. Ioannidis JP. Gene associations: false or true? Trend Mol Med 2003 9:135 8.
40. Saito YA, Talley NJ, De Andrade M, Petersen GM. Case-control genetic association studies in gastrointestinal disease: review and recommendations. Am J Gastroenterol 2006 101:1379 89.
41. Garcia-Gonzalez MA, Lanas A, Quintero E, et al. Gastric cancer susceptibility is not linked to pro- and anti-inflammatory cytokine gene polymorphisms in whites: a nationwide multicenter study in Spain. Am J Gastroenterol 2007 102:1878 92.
42. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric carcinoma. N Engl J Med 1991 325:1127 31.